featured
Oral Corticosteroid Dosage and Taper Duration at Onset Influence Time to First Relapse in Patients With MOGAD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse
J. Neurol. Neurosurg. Psychiatr. 2024 May 16;[EPub Ahead of Print], BP Trewin, RC Dale, J Qiu, M Chu, N Jeyakumar, F Dela Cruz, J Andersen, P Siriratnam, KKM Ma, TA Hardy, A van der Walt, J Lechner-Scott, H Butzkueven, SA Broadley, MH Barnett, SW Reddel, F Brilot, T Kalincik, S RamanathanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.